Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

Recruiting

Phase 2

Tumor Infiltrating LymphocytesAdoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma

Sponsor:

Udai Kammula

Code:

NCT03467516

Conditions

Uveal Neoplasms

Melanoma, Uveal

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Tumor Infiltrating Lymphocytes (TIL)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-26. This information was provided to ClinicalTrials.gov by Udai Kammula on 2025-07-10.